{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:24:31Z","timestamp":1761920671613,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bbmt.2019.12.764","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T09:04:36Z","timestamp":1577783076000},"page":"625-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunosuppressive Drugs Alter \u03b11-Antitrypsin Production in Hepatocytes: Implications for Epithelial Gap Repair"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1774-5423","authenticated-orcid":false,"given":"Ido","family":"Brami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dor","family":"Ini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nofit","family":"Sassonker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melodie","family":"Zaknoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsila","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli C.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.12.764_bib0001","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.anclin.2017.04.001","article-title":"Overview of immunosuppressive therapy in solid organ transplantation","volume":"35","author":"Holt","year":"2017","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0002","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bmt.2016.298","article-title":"The EBMT-ELN Working Group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis","volume":"52","author":"Ruutu","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0003","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1172\/JCI90592","article-title":"Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis","volume":"127","author":"Ferrara","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0004","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1172\/JCI99261","article-title":"Survival signal REG3\u03b1 prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease","volume":"128","author":"Zhao","year":"2018","journal-title":"J Clin Invest"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2019.12.764_bib0005","first-page":"S21","article-title":"Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD)","volume":"7","author":"Matsukuma","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0006","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fphar.2018.00341","article-title":"The multifaceted effects of alpha1-antitrypsin on neutrophil functions","volume":"9","author":"Janciauskiene","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0007","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cei.12476","article-title":"Acute-phase protein \u03b11-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats","volume":"179","author":"Guttman","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/bst0300093","article-title":"Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin","volume":"30","author":"Kalsheker","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0009","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1089\/scd.2017.0099","article-title":"Oncostatin M and TNF-\u03b1 induce Alpha-1 Antitrypsin production in undifferentiated adipose stromal cells","volume":"26","author":"Ni","year":"2017","journal-title":"Stem Cells Dev"},{"issue":"suppl 4","key":"10.1016\/j.bbmt.2019.12.764_bib0010","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1513\/AnnalsATS.201507-468KV","article-title":"Well-known and less well-known functions of alpha-1 antitrypsin. Its role in chronic obstructive pulmonary disease and other disease developments","volume":"13","author":"Janciauskiene","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00154-2016","article-title":"The prevalence of diagnosed \u03b11-antitrypsin deficiency and its comorbidities: results from a large population-based database","volume":"49","author":"Greulich","year":"2017","journal-title":"Eur Respir J"},{"issue":"144","key":"10.1016\/j.bbmt.2019.12.764_bib0012","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/imm.12403","article-title":"\u03b11-Antitrypsin modifies general natural killer cell interactions with dendritic cells and specific interactions with islet \u03b2-cells in favour of protection from autoimmune diabetes","author":"Guttman","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0013","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4049\/jimmunol.1101340","article-title":"\u03b1-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells","volume":"189","author":"Ozeri","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0014","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1182\/blood-2014-04-570440","article-title":"\u03b1-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics","volume":"124","author":"Marcondes","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.omtm.2018.10.007","article-title":"Alpha 1 antitrypsin gene therapy extends the lifespan of lupus-prone mice","volume":"11","author":"Elshikha","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0016","first-page":"3","article-title":"\u03b11-Antitrypsin therapy for non-deficient individuals: integrating and mitigating cross-pathology inflammatory and immune responses to the injured cell","author":"Lewis","year":"2017","journal-title":"Intern Med Rev"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0017","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/bmt.2015.109","article-title":"Fecal calprotectin and \u03b11-antitrypsin dynamics in gastrointestinal GvHD","volume":"50","author":"O'Meara","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0018","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1182\/blood-2011-12-397968","article-title":"Fecal calprotectin and \u03b1-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease","volume":"119","author":"Rodriguez-Otero","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0019","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2017-11-815746","article-title":"\u03b11-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease","volume":"131","author":"Magenau","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0020","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbmt.2016.05.011","article-title":"Response of steroid-refractory acute GVHD to \u03b11-antitrypsin","volume":"22","author":"Marcondes","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0021","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02912914","article-title":"Serum alpha-2-macroglobulin, antitrypsin and antichymotrypsin activities in patients receiving treatment with cyclosporine","volume":"21","author":"Roche","year":"2006","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0022","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1089\/scd.2017.0099","article-title":"Oncostatin M and TNF-\u03b1 induce alpha-1 antitrypsin production in undifferentiated adipose stromal cells","volume":"26","author":"Ni","year":"2017","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0023","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.tiv.2015.04.013","article-title":"The effects of drugs with immunosuppressive or immunomodulatory activities on xenobiotics-metabolizing enzymes expression in primary human hepatocytes","volume":"29","author":"Vrzal","year":"2015","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0024","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1258\/ebm.2010.009297","article-title":"Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model","volume":"235","author":"Kaushal","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1190354","article-title":"An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis","volume":"329","author":"Hidvegi","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0026","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/art.1780380719","article-title":"End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiency","volume":"38","author":"Hilsden","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0027","first-page":"267","article-title":"Alpha-1 antitrypsin substitution for extrapulmonary conditions in alpha-1 antitrypsin deficient patients","volume":"5","author":"Baranovski","year":"2018","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0028","doi-asserted-by":"crossref","DOI":"10.3791\/56993","article-title":"Purification of hepatocytes and sinusoidal endothelial cells from mouse liver perfusion","author":"Cabral","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0029","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.pharep.2016.06.001","article-title":"Transplant drugs affect the expression of phase II and antioxidant enzymes in human carcinoma cells HepG2 but not in primary cultures of human hepatocytes: in vitro comparative study","volume":"68","author":"Vrzal","year":"2016","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138522","article-title":"Effect of immunosuppressive agents on hepatocyte apoptosis post-liver transplantation","volume":"10","author":"Lim","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0031","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1038\/s41467-019-11895-2","article-title":"Caspase-11 signaling enhances graft-versus-host disease","volume":"10","author":"Lu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0032","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jhep.2018.01.008","article-title":"Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation","volume":"68","author":"Gehrke","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200897","article-title":"NorUDCA promotes degradation of \u03b11-antitrypsin mutant Z protein by inducing autophagy through AMPK\/ULK1 pathway","volume":"13","author":"Tang","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0034","doi-asserted-by":"crossref","first-page":"G851","DOI":"10.1152\/ajpgi.00175.2003","article-title":"Mitochondrial autophagy and injury in the liver in alpha1-antitrypsin deficiency","volume":"286","author":"Teckman","year":"2004","journal-title":"Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1742-481X.2012.00950.x","article-title":"Effects of immunosuppressive therapy on wound healing","volume":"10","author":"Bootun","year":"2013","journal-title":"Int Wound J"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0036","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":"Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0037","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1034\/j.1600-6143.2003.00185.x","article-title":"Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation","volume":"3","author":"Valente","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0038","first-page":"3520","article-title":"Risk factors for wound healing complications in sirolimus-treated renal transplant recipients","volume":"38","year":"2006"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0039","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00042728-200802000-00011","article-title":"The effects of sirolimus on wound healing in dermatologic surgery","volume":"34","author":"Brewer","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amsu.2018.08.006","article-title":"Optimal surgical management in kidney and pancreas transplantation to minimise wound complications: a systematic review and meta-analysis","volume":"33","author":"Shahrestani","year":"2018","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0041","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/TXD.0000000000000591","article-title":"The effect of mycophenolate mofetil on early wound healing in a rodent model","volume":"2","author":"Willems","year":"2016","journal-title":"Transplant Direct"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0042","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.106.117051","article-title":"In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil","volume":"321","author":"Roos","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0043","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1139\/bcb-2013-0018","article-title":"Mycophenolic acid affects basic functions of human keratinocytes in the IMPDH-dependent manner","volume":"91","author":"Borowczyk","year":"2013","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0044","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ajh.24631","article-title":"The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus-host disease after stem-cell transplantation from unrelated donors","volume":"92","author":"Yerushalmi","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.leukres.2013.12.012","article-title":"Mycophenolate mofetil vs. methotrexate for the prevention of graft-versus-host-diseasesystematic review and meta-analysis","volume":"38","author":"Ram","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0046","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood-2014-06-577023","article-title":"Phase 3 clinical trial of steroids\/mycophenolate mofetil vs steroids\/placebo as therapy for acute GVHD: BMT CTN 0802","volume":"124","author":"Bola\u00f1os-Meade","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0047","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/S2352-3026(19)30088-2","article-title":"Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial","volume":"6","author":"Sandmaier","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0048","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/S2352-3026(18)30221-7","volume":"6","author":"Bola\u00f1os-Meade","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0049","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.1601810","article-title":"Neutrophil microparticles deliver active myeloperoxidase to injured mucosa to inhibit epithelial wound healing","volume":"198","author":"Slater","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2018.08.021","article-title":"TNF\u03b1 gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis","volume":"287","author":"Xiao","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0051","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.118.249524","article-title":"Inhibition of intestinal epithelial wound healing through protease-activated receptor-2 activation in Caco2 cells","volume":"367","author":"Fernando","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0052","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s10020-019-0084-3","article-title":"Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"25","author":"Mirea","year":"2019","journal-title":"Mol Med"},{"key":"10.1016\/j.bbmt.2019.12.764_bib0053","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3389\/fimmu.2016.00559","article-title":"Context-specific and immune cell-dependent antitumor activities of \u03b11-antitrypsin","volume":"7","author":"Guttman","year":"2016","journal-title":"Front Immunol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911931732X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911931732X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:55Z","timestamp":1761059335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387911931732X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S108387911931732X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.12.764","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppressive Drugs Alter \u03b11-Antitrypsin Production in Hepatocytes: Implications for Epithelial Gap Repair","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.12.764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}